These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24309224)

  • 1. Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome.
    Xu S; Tang L; Mi Y; Jiang J; Zhu M; Chen B; Wang B; Li T; Xu C; Wang J; Lu X; Ge W; Wang L; Huang J
    Clin Invest Med; 2013 Dec; 36(6):E282-9. PubMed ID: 24309224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome].
    Wang B; Xu SS; Jiang JJ; Lu XB; Xue YS; Wang JC; Mi YF; Zhu M; Ge WL; Tang LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):416-20. PubMed ID: 22883094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].
    Yang L; Tian X; Guo R; Liu H; Qi F; Ye J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):740-3. PubMed ID: 25511093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion].
    Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Extracellular Matrix Metalloproteinase Inducer in Peripheral Blood and Serum MMPs in patients with Acute Coronary Syndrome.
    Wang W
    Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):97-104. PubMed ID: 37114301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages.
    Wang QM; Wang H; Li YF; Xie ZY; Ma Y; Yan JJ; Gao YF; Wang ZM; Wang LS
    Cell Physiol Biochem; 2016; 39(6):2308-2319. PubMed ID: 27832636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
    Xie SL; Chen YY; Zhang HF; Deng BQ; Shu XR; Su ZZ; Lin YQ; Nie RQ; Wang JF
    Transl Res; 2015 Mar; 165(3):387-95. PubMed ID: 25267095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
    Fukuda D; Shimada K; Tanaka A; Kusuyama T; Yamashita H; Ehara S; Nakamura Y; Kawarabayashi T; Iida H; Yoshiyama M; Yoshikawa J
    Am J Cardiol; 2006 Jan; 97(2):175-80. PubMed ID: 16442358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
    Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
    Fan Y; Wang J; Wei L; He B; Wang C; Wang B
    Int J Cardiol; 2011 Oct; 152(1):49-55. PubMed ID: 20674992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages.
    Cao J; Han Z; Tian L; Chen K; Fan Y; Ye B; Huang W; Wang C; Huang Z
    J Transl Med; 2014 Sep; 12():266. PubMed ID: 25241044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.
    Major TC; Liang L; Lu X; Rosebury W; Bocan TM
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1200-7. PubMed ID: 12117738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
    Nie R; Xie S; Du B; Liu X; Deng B; Wang J
    Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of matrix metalloproteinase-9 and tissue factors secreted by cultured monocyte-derived macrophage of patients with coronary heart disease in vitro and the intervenient effect of puerarin on them].
    Li DY; Wang ZL; Xia Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):692-5. PubMed ID: 17879530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.
    Opstad TB; Seljeflot I; Bøhmer E; Arnesen H; Halvorsen S
    Cardiology; 2018; 139(1):17-24. PubMed ID: 29141241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
    Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
    Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.
    Huang Z; Wang L; Meng S; Wang Y; Chen T; Wang C
    Int J Cardiol; 2011 Jan; 146(2):153-8. PubMed ID: 19576641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.